Overview: Why toxicity matters in multispecific antibodies and immune-cell engagers The ESMO Therapeutic Landscapes webinar series returns in 2026 with a focused session on the toxicity profiles of next-generation biologics. Multispecific antibodies and immune-cell engagers represent a rapidly advancing frontier in cancer therapy, offering the promise of simultaneous targeting of tumor antigens and immune cells.…